AAAAAA

   
Results: 1-9 |
Results: 9
A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery
Authors: Karkouti, K Cohen, MM McCluskey, SA Sher, GD
Citation: K. Karkouti et al., A multivariable model for predicting the need for blood transfusion in patients undergoing first-time elective coronary bypass graft surgery, TRANSFUSION, 41(10), 2001, pp. 1193-1203
Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection
Authors: Chang, H Hall, GA Geerts, WH Greenwood, C McLeod, RS Sher, GD
Citation: H. Chang et al., Allogeneic red blood cell transfusion is an independent risk factor for the development of postoperative bacterial infection, VOX SANGUIN, 78(1), 2000, pp. 13-18
Effect of transfusion on lipid peroxidation products in the plasma of thalassemic patients (letter). (vol 39, pg 333, 1999)
Authors: Sher, GD Bartfay, WJ Liu, P Lehotay, DC
Citation: Gd. Sher et al., Effect of transfusion on lipid peroxidation products in the plasma of thalassemic patients (letter). (vol 39, pg 333, 1999), TRANSFUSION, 40(5), 2000, pp. 620-620
Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases
Authors: McCullough, J Bianco, C Bracey, A Busch, M Dodd, RY Gammon, RR Harrison, C Jackson, JB Katz, LM Kleinman, S McFarland, J Page, P Preston, S Sher, GD Sherman, L Simon, T Stramer, SL Stroncek, D Young, CT Hewlett, IK
Citation: J. Mccullough et al., Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases, TRANSFUSION, 40(2), 2000, pp. 143-159
Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood
Authors: Chang, H Voralia, M Bali, M Sher, GD Branch, DR
Citation: H. Chang et al., Irreversible loss of donor blood leucocyte activation may explain a paucity of transfusion-associated graft-versus-host disease from stored blood, BR J HAEM, 111(1), 2000, pp. 146-156
The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in Canada
Authors: Chang, H Sher, GD Blanchette, VS Teitel, JM
Citation: H. Chang et al., The impact of inhibitors on the cost of clotting factor replacement therapy in haemophilia A in Canada, HAEMOPHILIA, 5(4), 1999, pp. 247-252
Prospective audit of cytomegalovirus-negative blood product utilization inhaematology/oncology patients
Authors: Chang, H Hawes, J Hall, GA Fuller, K Francombe, WH Zuber, E Sher, GD
Citation: H. Chang et al., Prospective audit of cytomegalovirus-negative blood product utilization inhaematology/oncology patients, TRANSFUS M, 9(3), 1999, pp. 195-198
Hydroxyurea use during pregnancy: A case report in sickle cell disease andreview of the literature
Authors: Diav-Citrin, O Hunnisett, L Sher, GD Koren, G
Citation: O. Diav-citrin et al., Hydroxyurea use during pregnancy: A case report in sickle cell disease andreview of the literature, AM J HEMAT, 60(2), 1999, pp. 148-150
Effect of transfusion on lipid peroxidation products in the plasma of thalassemic patients
Authors: Sher, GD Bartfay, WJ Liu, PP Lehotay, DC
Citation: Gd. Sher et al., Effect of transfusion on lipid peroxidation products in the plasma of thalassemic patients, TRANSFUSION, 39(3), 1999, pp. 333-334
Risultati: 1-9 |